HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexate.

Abstract
Human immunodeficiency virus (HIV)-related CD8+ cutaneous pseudolymphoma (CD8+ cytotoxic T cell skin infiltrative disease) is an inflammatory process resulting from a massive infiltration of the skin by activated, oligoclonal, HIV-specific, cytotoxic T lymphocytes. Usually, CD8+ cutaneous pseudolymphoma affects patients with a deep immunosuppression, and is rare in patients with mild immunosuppression. In deeply immunocompromised patients, highly active antiretroviral therapy (HAART) is considered as the first-line treatment. In contrast, the choice of therapy in moderately immunocompromised patients and/or patients already receiving HAART remains nonconsensual. We report a case of HIV-related CD8+ cutaneous pseudolymphoma in a moderately immunocompromised patient who was successfully and safely treated with methotrexate. We review the literature on HIV-related CD8+ pseudolymphoma and the use of methotrexate in HIV-positive patients.
AuthorsS Ingen-Housz-Oro, E Sbidian, N Ortonne, D Penso-Assathiany, V Chambrin, M Bagot, H Bachelez, P Wolkenstein, O Chosidow
JournalDermatology (Basel, Switzerland) (Dermatology) Vol. 226 Issue 1 Pg. 15-8 ( 2013) ISSN: 1421-9832 [Electronic] Switzerland
PMID23343593 (Publication Type: Case Reports, Journal Article, Review)
CopyrightCopyright © 2013 S. Karger AG, Basel.
Chemical References
  • Dermatologic Agents
  • Methotrexate
Topics
  • Antiretroviral Therapy, Highly Active (methods)
  • CD8-Positive T-Lymphocytes (drug effects)
  • Dermatologic Agents (therapeutic use)
  • HIV Infections (drug therapy, immunology)
  • Humans
  • Immunocompromised Host
  • Male
  • Methotrexate (therapeutic use)
  • Middle Aged
  • Pseudolymphoma (drug therapy, immunology)
  • Skin Diseases (drug therapy, immunology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: